Freeze and fight: new combo tackles spread bladder cancer
NCT ID NCT04701918
First seen Jan 07, 2026 · Last updated Apr 28, 2026 · Updated 20 times
Summary
This study tested a combination treatment for people with advanced bladder cancer that has spread. It used a procedure called cryoablation (freezing tumors) along with immunotherapy drugs (pembrolizumab or avelumab) to see if the immune system could better attack remaining tumors. Only 9 participants were enrolled, and the main goal was to measure how many tumors shrank or disappeared.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.